ID: ALA3983380

Max Phase: Preclinical

Molecular Formula: C22H19N5O3

Molecular Weight: 401.43

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1cc(/C=C/c2cn3ccnc(N4CCOCC4)c3n2)nc2ccccc12

Standard InChI:  InChI=1S/C22H19N5O3/c28-22(29)18-13-15(24-19-4-2-1-3-17(18)19)5-6-16-14-27-8-7-23-20(21(27)25-16)26-9-11-30-12-10-26/h1-8,13-14H,9-12H2,(H,28,29)/b6-5+

Standard InChI Key:  YMCNDWSLVNYLPN-AATRIKPKSA-N

Associated Targets(Human)

Phosphodiesterase 10A 5542 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A 1396 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 401.43Molecular Weight (Monoisotopic): 401.1488AlogP: 2.98#Rotatable Bonds: 4
Polar Surface Area: 92.85Molecular Species: ACIDHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.66CX Basic pKa: 2.81CX LogP: 2.29CX LogD: -0.71
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.56Np Likeness Score: -1.20

References

1.  (2016)  PDE10a inhibitors for the treatment of type II diabetes, 

Source

Source(1):